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Abstract
Patients with the autosomal dominant form of Emery-Dreifuss muscular dystrophy (EDMD) or familial partial lipodystrophy (FPLD)
have specific mutations in the lamin A gene. Three such point mutations, G465D (FPLD), R482L, (FPLD), or R527P (EDMD), were
introduced by site-specific mutagenesis in the C-terminal tail domain of a FLAG-tagged full-length lamin A construct. HeLa cells were
transfected with mutant and wild-type constructs. Lamin A accumulated in nuclear aggregates and the number of cells with aggregates
increased with time after transfection. At 72 h post transfection 60–80% of cells transfected with the mutant lamin A constructs had
aggregates, while only 35% of the cells transfected with wild-type lamin A revealed aggregates. Mutant transfected cells expressed 10–24,
and wild-type transfected cells 20, the normal levels of lamin A. Lamins C, B1 and B2, Nup153, LAP2, and emerin were recruited into
aggregates, resulting in a decrease of these proteins at the nuclear rim. Aggregates were also characterized by electron microscopy and found
to be preferentially associated with the inner nuclear membrane. Aggregates from mutant constructs were larger than those formed by the
wild-type constructs, both in immunofluorescence and electron microscopy. The combined results suggest that aggregate formation is in part
due to overexpression, but that there are also mutant-specific effects.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Mutations in the lamin A gene have been shown to be
responsible for six human diseases. The myopathies include
dilated cardiomyopathy (DCM) with conduction system de-
fects [1], limb girdle muscular dystrophy 1B with atrioven-
tricular conduction disturbances (LGMD1B) [2], and the
autosomal dominant form of Emery-Dreifuss muscular dys-
trophy (EDMD) [3,4]. This latter disease is characterized by
early contractures of the ankles, elbows, and Achilles’ ten-
dons, slowly progressive muscle wasting, and weakness and
in some cases cardiomyopathy with conduction block [5].
The fourth disease is Dunnigan-type familial partial lipo-
dystrophy (FPLD) [6–8]. Patients suffering from FPLD
show complete or partial absence of adipose tissues from
the extremeties and trunk after puberty [9]. Additional dis-
eases associated with mutations in the lamin A gene are
autosomal recessive axonal neuropathy (Charcot-Marie-
Tooth disorder type 2) [10] characterized by muscle weak-
ness and wasting, foot deformities, and electrophysiological
as well as histological changes, and mandibuloacral dyspla-
sia, a rare autosomal recessive disorder characterized by
postnatal growth retardation, craniofacial anomalies, skele-
tal malformations, and mottled cutaneous pigmentation
[11]. Mutations causing each of the above diseases have
been mapped along the lamin A gene (reviewed by Gen-
schel and Schmidt [12] and Hutchison et al. [13]).
Lamins A and C arise from alternatively spliced forms of
the lamin A gene and diverge only at their C-termini [14–
16]. Expression of the lamin A/C gene is developmentally
regulated. In mice lamin A/C expression is not found in
cells of the early embryo or in undifferentiated teratocarci-
noma cell lines. It is detected in the embryo proper first at
embryonic day 12 in certain muscle cells, but begins to be
expressed only at 15 days after birth in brain [17,18]. Stem
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cells of the immune and hemopoietic systems lack lamin
A/C even in adult animals [19]. In contrast, lamins B1 and
B2 are encoded by two distinct genes and are thought to be
constituitively expressed irrespective of developmental
stage [20–22] and, indeed, B-type lamins are found at all
stages of mouse development [18]. A third B-type lamin—
lamin B3—is a splice variant of lamin B2 and its expression
is limited to male germ cells [23].
Knockout of the lamin A gene in mice results in mice
that at birth cannot be distinguished from wild-type, except
for some redistribution of emerin, a protein of the inner
nuclear membrane. However, such mice show severely re-
tarded postnatal growth, develop muscular dystrophy, and
die at 6–8 weeks of age. Thus, the pathology of the lamin
A knockout mice is strikingly similar to that seen with
human EDMD [24]. RNA interference experiments on
lamins in human HeLa cells have shown that silencing of
the lamin A gene did not affect cell growth, but did lead to
a redistribution of emerin. These results show that lamin A
is not an essential protein in HeLa cells. In contrast, lamin
B1 and lamin B2 are essential since silencing of these genes
leads to apoptosis [25].
The nuclear lamina underlies the inner membrane of the
nuclear envelope [26]. This 10–20-nm layer is built of
polymers formed by the nuclear lamins, which are most
probably arranged as a net, although this ultrastructural
feature has so far only been demonstrated for the Xenopus
oocyte [27]. It is thought to play a critical role in maintain-
ing the structural integrity of the nuclear envelope, but may
also have additional functions. The lamina is connected to
the nuclear envelope by lamin-binding proteins that are
integral membrane proteins of the inner nuclear membrane.
This latter class includes three isoforms of lamina-associ-
ated protein 1 (LAPI A, B, and C), at least five isoforms of
LAP2, emerin, and the lamin B receptor [28,29]. A sixth
isoform of LAP2, LAP2, lacks an inner nuclear mem-
brane-binding domain [28]. Emerin binds specifically to
A-type lamins both in vivo [30,24] and in vitro [31].
LAP1A and LAP1B specifically bind to lamin A, C, and B1
[32], while LAP2 is associated exclusively with A-type
lamins [33] and lamin B receptor interacts with B-type
lamins [34]. The lamina is also associated with nuclear pore
complexes perhaps through a tight association of nuclear
lamins with Nup153, a peripheral nuclear pore component
[35]. Interactions between the nuclear lamina and chromatin
are thought to be mediated through the C-terminal lamin
sequences [36].
To understand how different mutations in the lamin A
molecule can affect lamina assembly and nuclear organiza-
tion, we and others have used additional approaches with
cells in culture. In the first approach, primary cultures of
fibroblasts from FPLD patients with heterozygous muta-
tions in lamin A at position 482 were studied [37]. Dysmor-
phic nuclei were seen in fibroblasts from three patients. The
frequency with which such abnormalities were observed
varied between 5% and 22%, depending on the patient and
the passage number, while 2–4% of control fibroblasts had
similar abnormalities. Equivalent studies have not yet been
performed with cells from patients with the other three
diseases. In a second approach, point mutations were in-
serted into the full-length lamin A cDNA and used to
transfect cells in culture [38,39]. Changes were seen in the
lamin A arrangement after transfecting HeLa cells with two
point mutants that cause DCM and a single mutant that
causes EDMD, but not with a point mutation causing FPLD
[38]. In a second study, aggregate formation was seen in the
lamin A arrangement after transfecting C2C12 myoblasts
with four mutants, one of which causes DCM and three of
which cause EDMD [39]. No change was seen in the same
study with 11 other mutant constructs, three of which cause
DCM, five of which cause EDMD, and three cause FPLD.
Our own interest in lamin A led us to make several mutant
lamin A constructs that cause EDMD and FPLD in parallel
to the studies reported by O¨ stlund et al. [39] and Raharjo et
al. [38]. Our results suggest that, as argued by others, there
are mutant-specific effects. In addition, however, they give
insight into lamin A aggregate formation. This phenomenon
was reported by O¨ stlund et al. [39] with mutant, but not with
the wild-type, lamin A construct. Our data show that both
the mutant and the wild-type lamin A constructs form ag-
gregates. At any time point the mutant cultures have about
twice as many transfected cells with aggregates as do the
wild-type cultures. Other lamins, as well as several lamin-
associated proteins, are recruited into the aggregates. Ag-
gregates have been characterized not only by immunofluo-
rescence microscopy but also by electron microscopy, and
the majority are shown to underlie the nuclear membrane.
Materials and methods
Plasmid construction and mutagenesis
All cloning procedures were performed according to
standard methods [40]. cDNA encoding lamin A, cloned
into the XhoI and EcoRI restriction site of the pCR 2.1-
TOPO vector (Invitrogen, Groningen, NL), was excised by
restriction endonuclease digestion with XhoI and EcoRI and
ligated into the pCS2 vector and digested with the same
restriction enzymes, pCS2 vector is a pBluescript II KS
-based plasmid [41] containing a FLAG-tag coding se-
quence inserted between the BamHI and EcoRI restriction
sites by K. Ko¨bernick (Department of Developmental Bio-
chemistry, University of Go¨ttingen, Germany). Point muta-
tions were introduced into the full-length lamin cDNA using
the QuikChange site-directed mutagenesis kit (Stratagene,
La Jolla, CA).
Cell culture and transfection
HeLa SS6 cells were grown at 37°C with 5% CO2 in
Dulbecco’s modified Eagle’s medium supplemented with
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10% fetal calf serum, penicillin, and streptomycin. Cells
were regularly passaged to maintain exponential growth.
The day before transfection, cells were trypsinized, diluted
with fresh medium without antibiotics, and transferred to
35-mm dishes. Transient transfection of plasmid DNA was
carried out by using Polyfect transfection reagent exactly as
described by the manufacturer (Qiagen, Hilden, Germany).
Cells were fixed and processed for immunofluorescence
microscopy between 24 and 100 h post transfection. Half
the medium was changed 3 days post transfection.
Cells that were trypsinized and replated were incubated
for 2.5 min with TE buffer [0.1% trypsin, 0.5 mM EDTA in
phosphate-buffered saline (PBS), pH 7.8], carefully resus-
pended, centrifuged (4 min, 1000 rpm), washed, and re-
plated on coverslips marked with a grid (CELLocate, Ep-
pendorf, Hamburg, Germany) at dilutions varying between
1:20 and 1:160.
Immunofluorescence microscopy
Cells grown on glass coverslips were fixed in methanol
for 6 min at 10°C. Following (PBS) washes, the fixed
cells were incubated with the first antibody for 30 min at
37°C, washed with PBS, incubated with the second anti-
body for 30 min at 37°C, again washed with PBS, and
mounted in Mowiol 4–88 (Hoechst, Frankfurt, Germany).
The primary antibodies were monoclonal lamin A, JOL4
(Abcam, Cambridge, UK), monoclonal lamin B1, clone L-5
(Zymed Inc., San Francisco, CA), monoclonal lamin B2,
clone LN43.2 (Novocastra, Newcastle, UK), polyclonal
lamin C (Christopher Hutchison, University of Durham,
UK), monoclonal emerin, clone 4G5 (Novocastra), mono-
clonal anti-FLAG M2 (Sigma-Aldrich, Deisenhofen, Ger-
many), polyclonal anti-FLAG (Sigma-Aldrich), monoclonal
LAP2, clone 27 (Transduction Laboratories, Lexington,
KY), and monoclonal Nup153 (Brian Burke, University of
Gainesville, FL). Appropriate dilutions of all antibodies
were established by immunofluorescence microscopy.
Second antibodies obtained from Dianova (Hamburg,
Germany) were fluorescein isothiocyanate-conjugated goat
anti-mouse IgGs, rhodamine-conjugated goat anti-mouse
IgGs, and rhodamine-conjugated goat anti-rabbit IgGs.
A Zeiss Axiophot with an F Fluar 40/1.30 oil objective
was used to collect digital images, which were further pro-
cessed with MetaMorph Imaging Software (Universal Im-
aging Corporation, West Chester, PA).
Transmission electron microscopy
Cells on 12-mm glass coverslips were fixed in glutaral-
dehyde (2% in 0.1 M cacodylate, pH 7.2, 0.1 M sucrose) for
45 min at room temperature. They were rinsed several times
with 0.1 M cacodylate, pH 7, containing 0.1 M sucrose and
then briefly in distilled water. Following fixation with os-
mium tetroxide (2% in 0.1 M cacodylate, pH 7.2, 0.1 M
sucrose), cells were stained en bloc with uranyl acetate (1%
in water) overnight at 4°C in the dark. The cells were
dehydrated in a graded series of ethanol and propylene
oxide and flat-embedded in Epon. After polymerization of
the Epon the coverslips were removed by etching in 48%
hydrofluoric acid for 20 min at room temperature. They
were rinsed three times in distilled water and dried over-
night at 60°C. The flat-embedded cells were sectioned se-
rially parallel to the substratum. Sections were stained with
uranyl acetate and lead citrate and examined in a Philips
CM12 transmission electron microscope. Sections were ap-
proximately 90–100 nm thick and nuclear aggregates were
most abundant between sections 25 and 35.
Immunoblotting
Monoclonal 636 lamin A/C specific antibody [42] was
used as hybridoma supernatant at a 1/100 dilution. For
Western blotting, transfected cells grown in 2-ml dishes
were trypsinized 3 days post transfection and harvested in
Sodium dodecyl sulfate sample buffer (Bio-Rad Laborato-
ries, Hercules, CA). Equal amounts of extract were sepa-
rated on different lanes of a 12.5% polyacrylamide gels and
transferred to nitrocellulose. Immunostaining was carried
out by using the Renaissance Western Blot Chemilumines-
cence Reagent (NEN, Boston, MA) and analyzed by using
the Lumi-Imager (Boehringer Mannheim, Mannheim, Ger-
many) equipped with LumiAnalyst Version 3.0 software.
The blots were then stripped by using the Western Blot
Recycling kit (Chemicon International, Temecula, CA) and
reprobed with the V9 vimentin antibody [43].
Statistical methods
Results are expressed as means the standard deviation.
Statistical analyses of aggregate size were performed with
the Student’s t test using Excel software.
Results
Abnormal organization of lamin A and formation of
nuclear aggregates
HeLa cells were transiently transfected with plasmids
containing wild-type and mutated forms of lamin A. A
FLAG epitope was present at the N-terminus of each con-
struct, and lamin A was detected by indirect immunofluo-
rescence with FLAG antibody. Results are shown in Fig. 1A
for the wild-type lamin A construct and for the three lamin
A mutations, i.e., G465D, R482L, and R527P. Lamin A
molecules with G465D [8] and R482L [7] mutations have
been reported in patients with FPLD, while the R527P
mutation has been reported in a patient with EDMD [3]. All
three mutations lie in the carboxy-terminal tail region in a
subdomain characterized by the atomic structure of an Ig-
like domain [44,45].
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The data summarized in Fig. 1A show results at 24 and
72 h post transfection. At 24 h increased amounts of lamin
A are present in both wild-type and mutant lamin A trans-
fected cells, but the arrangement in most cells is comparable
to that seen in untransfected cells. Nuclear aggregates are
seen in 1–2% of cells in the cultures transfected with the
wild-type or with the G465D mutant construct. However,
already at this time point 7% of cells transfected with the
R527P mutant and 13% of cells transfected with the R482L
mutant construct show such aggregates (Fig. 1A). At 72 h
Fig. 1. (A) Nuclear localization of FLAG-tagged ectopically expressed wild-type and mutant forms of lamin A, 24 and 72 h post transfection. The panels
show immunofluorescence microscopy images of HeLa SS6 cells transfected with wild-type lamin A (WT) or with the three lamin A missense mutants as
indicated. Cells were stained with the mouse monoclonal antibody against FLAG and rhodamine-conjugated second antibody. Note the nuclear aggregates
visible 72 h post transfection in cells transfected with all three mutant constructs as well as in wild-type transfected cells. (B) Abnormal arrangements of lamin
A in individual HeLa cells transfected with the mutant G465D construct and stained with the monoclonal antibody against FLAG. (C) HeLa cells were
trypsinized and replated onto marked coverslips 72 h post transfection with the R527P mutant construct. Individual colonies were followed in phase
microscopy and photographed at 24 h (left) and at 48 h (not shown). At 72 h cells were fixed and stained for FLAG-tag to determine the lamin A location
and photographed in phase (middle) and in fluorescence microscopy (right). The three micrographs show the same colony of cells. The presence of a group
of eight cells with nuclear aggregates suggests that cells with aggregates can replicate (arrow). Magnifications: (A) 660, (B) 1359, and (C) 584.
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almost all of the FLAG-tagged lamin A is in the large
nuclear aggregates in the three cultures transfected with the
mutant constructs. However, such aggregates are also found
to a lesser extent in cells transfected with the wild-type
construct (Fig. 1A). Thus, at 72 h, 60–80% of the cells
transfected with the mutant lamin constructs have aggre-
gates when tested with the FLAG antibody, while at this
time point only 35% of cells transfected with wild-type
lamin A have aggregates. The kinetics of nuclear lamin
aggregate formation is shown in Fig. 2. Here, the percentage
of cells that contain nuclear aggregates has been plotted as
a function of time after transfection. Transfected cells were
followed for 96 h post transfection. At this time point
85–90% of cells transfected with the mutant cDNAs showed
aggregates, while only some 40% of cells transfected with
the wild-type cDNA had such aggregates (Fig. 2). Occa-
sional metaphase cells with aggregates were also seen.
Staining with Hoechst dye showed that DNA was excluded
from the nuclear aggregates. Transfected cells were also
tested with the TUNEL assay to determine the percentage of
apoptotic cells. Only 2–5% were apoptotic at 48 h post
transfection, and this number increased to 8–10% at 72 h
post transfection.
The size of the nuclear aggregates was dependent on the
time post transfection as well as on the particular mutant
cDNA used to transfect the cells. Nuclear aggregates in the
wild-type transfected cells were smaller than the aggregates
in the mutants G465D and R527P, which in turn were
smaller than those of the mutant R482L. Measurement of
the aggregate diameters from immunofluorescence micro-
graphs at 72 h post transfection yielded average values of
0.83  0.22 m for the wild-type, 1.03  0.41 m for the
mutant R527P, 1.02  0.31 m for the mutant G465D, and
1.54  0.54 m for the mutant R482L (Table 1). These
differences in size in aggregate diameter are significant for
wild-type vs. each of the three mutants and for R527P and
G465D vs. R482L (P  0.001). As far as the number of
aggregates is concerned, cells transfected with the R482L
mutant appeared to have fewer aggregates than cells trans-
fected with the other two mutant cDNAs at the same time
point (Table 1). Some FLAG-tagged lamin A was found
distributed throughout the nucleoplasm and underlying the
nuclear membrane, as well as in the nuclear aggregates.
This location of FLAG-tagged lamin A was more pro-
nounced in cells containing aggregates resulting from trans-
fection with the wild-type cDNA (Fig. 1A, row 2).
Finally, in some transfected cells and particularly in
those transfected with the mutant cDNAs, it was clear that
overexpression of lamin A resulted in additional bizarre
arrangements of lamin A. Lamin A was found in occasional
cells in whirls, or in large aggregates subsuming the nuclear
membrane, or in some instances even as aggregates in the
cytoplasm (Fig. 1B). Thus, the percentages of cells with
clearly aberrant lamin A arrangements are larger than those
shown in Fig. 2, which includes only those cells with clearly
identifiable nuclear aggregates.
Fibroblasts from patients with FPLD show aberrant nu-
clear morphologies after heat shock [37]. We therefore
tested whether the lamin A distribution seen in our experi-
ments was sensitive to heat shock 70 h post transfection.
Cells transfected with wild-type or the mutant DNA con-
structs were incubated at 42°C for 1 h and then tested with
the anti-FLAG antibody (data not shown). No change was
seen either in the nuclear shape or in the aggregates, sug-
Table 1
Comparison of aggregate diameter in wild-type and mutant cultures by
immunofluorescence (IF) and electron microscopy (EM)a
Wild-type R527P G465D R482L
IF
Mean 0.83 1.03 1.02 1.54
SD 0.22 0.41 0.31 0.54
n 141 89 53 35
EM
Mean 0.73 0.98 1.09 1.34
SD 0.22 0.33 0.44 0.54
n 77 62 98 53
a Ten cells with aggregates were chosen at random from immunofluo-
rescence (IF) and electronmicroscopy (EM) prints. The diameter of each
aggregate was measured, and the mean and standard deviations calculated.
Note the agreement between the values obtained for the aggregate diam-
eters in immunofluorescence and in electron microscopy. Note that the
aggregates in wild-type transfected cells were smaller than those in R527P
and G465D transfected cells, which in turn were smaller than those in
R482L transfected cells. (IF: wild-type vs. R527P, G465D, or R482L,
P  0.001: R527P or G465D vs. R482L, P  0.001; R527P vs. G465D,
not significant. For EM the P values are identical to those given for IF,
except for G465D vs. R482L, where P  0.005.) SD, standard deviation;
n, number of aggregates.
Fig. 2. The percentage of transfected cells in which nuclear aggregates can
be visualized is plotted against time post transfection for HeLa cells
transfected with each of the three mutant constructs and with wild-type
cDNA. At least 200 transfected cells were counted for each point. Note the
time-dependent increase of cells with aggregates, and that this increase is
slower in wild-type than in mutant transfected cultures. Data shown are
from a single experiment. Determination of the mean and standard devia-
tion for three experiments gave the following values expressed as percent-
ages of cells with aggregates 96 h post transfection: wild-type, 40.6 
5.2%; G465D, 85.4  1.2%; R482L, 81.9  3.8%; and R527P, 86.0 
3.2%. Interobserver variability in counting was 5%.
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gesting that under our conditions these structures are heat
shock insensitive.
To test whether HeLa cells with nuclear aggregates can
replicate, cells transfected with the R527P mutant construct
were trypsinized and replated on to marked coverslips 72 h
post transfection. Staining of a parallel coverslip showed
that prior to trypsinization 77% of the cells were transfected
and 39% of the transfected cells had aggregates. Several
colonies on the marked coverslips were selected and pho-
tographed 24, 48, and 72 h after replating. At 72 h after
replating (144 h post transfection) immunofluorescence
with the FLAG-tagged lamin A antibody showed that 17%
of the cells were transfected and that 27% of the transfected
cells had aggregates. Thus, transfected cells, as well as cells
with aggregates, survive replating although the percentage
of transfected cells decreases with time after replating. As
can be seen in Fig. 1C, the number of cells in an individual
colony increased with time. In such colonies often both
types of cells are visible, i.e., cells in which the FLAG-
tagged mutant lamin A shows a relatively normal distribu-
tion, as well as cells in which nuclear aggregates are clearly
apparent. Micrographs of the type shown in Fig. 1C, in
which clusters of cells apparently derived from a single cell
have aggregates, are consistent with the possibility that cells
with nuclear aggregates can replicate.
Levels of expression of lamin A in transfected cells
The data in Figs. 1A and 2 suggest strongly that forma-
tion of nuclear aggregates is caused at least in part by
overexpression of lamin A in the transfected cells. For this
reason we decided to measure the levels of overexpression
in HeLa cultures transfected with either the wild-type lamin
A or with the mutant lamin A constructs.
Extracts of untransfected (NT) and of wild-type (WT) or
mutant transfected HeLa cells obtained 72 h post transfec-
tion were subjected to sodium dodecyl sulfate–electro-
phoresis and immunoblotting with the 636 lamin monoclo-
nal antibody, which recognizes both lamin A and lamin C
(Fig. 3). The results obtained when the blots are scanned
with the Lumi-Imager are shown in panel A. The immuno-
blots were then stripped and reprobed with the V9 vimentin
antibody (panel B). The extent of overexpression expressed
either as real counts, or on a per-transfected-cell basis, is
shown in panel C. Both overexpression ratios assign an
arbitrary value of 1 to the untransfected culture grown in
parallel. The results show that on a per-transfected-cell basis
lamin A is overexpressed in the R482L culture by a factor
of 10, in the R527P culture by a factor of 20, and in the
G465D culture by a factor of 24. In the wild-type culture
lamin A is overexpressed by a factor of 20. The transfection
efficiency for the R482L construct in the experiment shown
in Fig. 3 was relatively low (20%) vs. those seen with the
G465D (75%) and R527P (70%) and the wild-type con-
struct (60%). However, in additional experiments in which
the R482L transfection rates were similar to wild-type,
overexpression/cell ratios similar to those shown in Fig. 3
were measured for R482L and for wild-type (data not
shown).
Thus, the combined results show that the lower rate of
nuclear aggregate formation seen with the wild-type vs. the
mutants is not a result of lower expression. The wild-type
cells express twice as much lamin A as the R482L-trans-
fected cultures and the same amount as the R527P cultures
on a per-transfected-cell basis.
Other lamins and lamina-associated proteins are
recruited into the aggregates
We next examined the location of proteins known to be
associated with the nuclear lamina in cells with nuclear
aggregates. Results are shown in Fig. 4 for HeLa cells
Fig. 3. (A) Untransfected (NT), wild-type (WT), or mutant transfected
HeLa cells were harvested 72 h post transfection and separated on sodium
dodecyl sulfate gels. Immunoblots of the extracts were assayed with the
lamin A/C 636 monoclonal antibody and read on the Lumi-Imager. Equal
amounts of extract were loaded. (B) The immunoblots were stripped and
reprobed with the V9 vimentin monoclonal antibody. (C) The unfilled bars
show the ratio of counts for lamin A for the cultures in A normalized to the
nontransfected culture arbitrarily assigned a value of 1. The black bars
show the extent of overexpression (OE) calculated on a per-transfected-cell
basis, again with the nontransfected culture assigned a value of 1. The WT
cultures express approximately twice as much lamin A as the R482L
culture and about the same amount as the R527P culture on a per-trans-
fected-cell basis. Note that the R482L culture expresses less lamin A on a
per-cell basis than do the cultures transfected with wild-type or with the
G465D and R527P mutants. The reduced aggregate formation seen with
the WT culture cannot therefore be explained by lower levels of lamin A
overexpression in the WT culture.
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transfected with the R527P lamin A mutant construct for
lamin C, lamin B1, lamin B2, LAP2, Nup153, and emerin
48 h post transfection. Examination of the individual panels
of Fig. 4 as well as of the overlays shows a colocalization to
the nuclear aggregates for five of the six proteins. The
endogenous lamin C is recruited into the aggregates when
probed in double label with a lamin C-specific antibody.
Little or no staining of the nuclear lamina is detected with
the lamin C antibody in the cells with aggregates (Fig. 4, top
row). Cells with aggregates stained with the monoclonal
lamin A antibody also showed little staining of the nuclear
lamina, but strong staining of the aggregates (data not
shown). Lamin B1, lamin B2, LAP2, and Nup153 also are
found in nuclear aggregates (Fig. 4, rows 2–5), but in
contrast staining of the nuclear lamina is seen with antibod-
ies to these proteins (Fig. 4, column 1). The sixth protein,
emerin, is found associated with the nuclear lamina in cells
without aggregates. A normal emerin stain with no staining
of the aggregates is seen in 55% of cells with aggregates.
Staining of the lamina, as well as an association with nu-
clear aggregates, is seen in approximately 40% of cells
showing such aggregates. It was usually stronger at the
periphery of the aggregates than in the center (Fig. 4, row
6). In very few cells in the culture ( 2%) a noncolocal-
ization of emerin with the FLAG-tagged lamin A was ob-
served. In such cells no staining of aggregates was seen with
the emerin antibody and staining of the nuclear lamina was
reduced. Instead emerin was detected in the cytoplasm as
small aggregates that may correspond to strands of the
endoplasmic reticulum, while lamin A was found in nuclear
aggregates (Fig. 4, row 7). In a further 2–3% of cells a
complete loss of emerin staining was observed. Overexpres-
sion of the R527P lamin A mutant cDNA thus causes an
aberrant localization and a redistribution of many of the
proteins normally associated with the nuclear envelope to
the nuclear aggregates.
Location of lamina proteins was also studied in HeLa
cells transfected with the mutants G465D and R527P as
well as with wild-type at 4 days post transfection. There was
only a single difference to the results presented in Fig. 4. At
4 days post transfection, emerin did not appear to colocalize
with nuclear aggregates in cells transfected with the wild-
type construct.
Electron microscopy of nuclear aggregates in lamin A-
transfected cells
HeLa cells transfected with the three mutant lamin A
cDNA constructs and with the wild-type cDNA construct
were subjected to electron microscopy at 73 h post trans-
fection. This time point was chosen to ensure that it would
be relatively easy to find cells in which nuclear aggregates
were present.
Examination of Fig. 5 shows that it is possible to obtain
electron micrographs in which large numbers of nuclear
aggregates are present in cells transfected with each of the
lamin A mutant constructs (Fig. 5A–C) and with the wild-
type lamin A construct (Fig. 5D). Measurement of the
aggregate diameter at 72 h post transfection yielded average
values of 0.73  0.22 m for the wild-type, 0.98  0.33
m for the mutant R527P, 1.09  0.44 m for the mutant
G465D, and 1.34  0.54 m for the R482L mutant. These
differences in size are significant for wild-type vs. R527P
and G465D and R482L and for R527P and G465D vs.
R482L (legend to Table 1). The size differences are also
apparent in Fig. 5 where panels A–D are shown at the same
magnification. Aggregates are sometimes found within the
nucleus, apparently unassociated with the nuclear mem-
brane (Fig. 5A and C) although occasionally (insert in Fig.
5C) a membrane fragment can be found attached to an
individual aggregate. However, by far, the majority of the
aggregates at this time point are found associated with and
often underlying the nuclear membrane (e.g., Fig. 5B). In
some cells aggregates are found that seem to push through
the nuclear membrane (e.g., Fig. 5C). In this process they
appear to become surrounded by a membrane. In a few cells
in which aggregates are clearly present in the cytoplasm
such aggregates also appear surrounded by a membrane. No
substructure was visible in the aggregates at higher resolu-
tion.
Discussion
Nuclear aggregates result in part from overexpression
and in part from mutant-specific effects
Our results show that all three mutations examined in our
study form nuclear aggregates, detectable both in immuno-
fluorescence and in electron microscopy, and that the num-
ber of such aggregates increased with time after transfection
(Fig. 2). Aggregate formation increases with time until at
96 h more than 80% of the transfected cells have aggregates.
New in our study is the observation that cells transfected
with the wild-type lamin A construct also show the nuclear
aggregates at later times, albeit to a lesser extent than the
three mutant lamin A constructs that we studied. Thus, at
96 h around 40% of cells transfected with the wild-type
construct have aggregates, i.e., about half the level seen
with the mutant transfected cells at the same time point.
The finding of aggregates in the wild-type transfected
cells, as well as the increase in nuclear aggregate formation
with time, suggests that aggregates may be formed in part as
a consequence of overexpression of mutant or wild-type
lamin A. Fig. 3 shows that mutant transfected cells overex-
press lamin A by a factor of 10–24, and wild-type by a
factor of 20, when compared to the untransfected cell level.
Two further arguments suggest a possible link between
overexpression and aggregate formation. First, primary cul-
tures of skin fibroblasts from patients with FPLD containing
the R482Q or R482W mutations show no aggregate forma-
tion. These cells express normal amounts of the mutant
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lamin A [37]. Second, aggregate formation was detected in
one study for mutant lamin B1 that resulted in a two- to
four-fold overexpression of lamin B1 [46], while it was not
seen in a study of mutant lamin B2 in which expression of
the mutant lamin was two- to four-fold less than of the
endogenous lamin [47].
Given our results that aggregate formation is dependent
on the time after transfection at which cells are examined, as
Fig. 4. Double immunofluorescence analysis of HeLa cells expressing the R527P mutant form of lamin A 48 h post transfection. For lamin C a mouse
anti-FLAG antibody and a rabbit lamin C antibody were used. For the other proteins a rabbit anti-FLAG antibody was used to reveal the FLAG-tagged mutant
lamin (middle panels) and a mouse antibody specific for each of the endogenous proteins (left panels). The aberrant localization of the mutated lamin A causes
the endogenous proteins to delocalize and become incorporated into the nuclear aggregates (see overlays in the third column). In all cases except lamin C,
considerable staining of the nuclear lamina is also observed. With emerin antibody a rim staining of the intracellular aggregates is seen in approximately half
the cells with aggregates (row 6). In a few cells (2%) emerin localizes not to the nuclear aggregates but to strands in the cytoplasm (row 7) (see text).
Magnification: 808.
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well as on the amount of lamin A synthesized, it is possible
to resolve discrepancies apparent in previous studies of cells
transfected with lamin A mutant constructs. Thus, in one
study [38] only a single mutant (N195K) was reported to
form aggregates when tested 20–24 h post transfection. In a
second study [39] transfection with four mutant lamin A
Fig. 5. Electron microscopy of HeLa cells transfected with mutant R527P (A); mutant R482L (B and inset in C); mutant G465D (C); and wild-type construct
(D). Note that many aggregates are found associated with the nuclear membrane and that aggregates are also found inside the nucleus (A, C, and D). Note
the association of the aggregate inside the nucleus with a fragment of nuclear membrane (inset in C). Magnifications: (A–D)8800 and (inset in C)10,000.
83K. Bechert et al. / Experimental Cell Research 286 (2003) 75–86
constructs (N195K, E358K, M371K, and R386K) resulted
in nuclear aggregates at 24 h post transfection. Eleven other
mutant lamin A constructs, including three that involve
changes at two of the same amino acid positions as used in
this study (R482Q, R482W, and R527P), did not form
aggregates at 24 h, the only time point that was tested. Our
data on all three mutants, and in particular on the R482L and
on the R527P mutant, show aggregate formation in a low
percentage of the cells at 24 h (13% for R482L and 7% for
R527P). Aggregate formation increases with time until after
100 h 85–90% of cells transfected with the mutant cDNA
constructs have aggregates.
Overexpression alone, however, seems insufficient to ex-
plain the quantitative difference between wild-type and mutant
cDNAs, since wild-type transfected cells express about twice
as much lamin A as the R482L mutant and about the same as
the R527P mutant. The data thus suggest that there is an
additional effect due to the specific mutations in the lamin A
gene. A further argument in support of mutant-specific effects
is the different sizes of the aggregates seen with the different
mutants and with the wild-type in both immunofluorescence
and electron microscopy (Figs. 1A and 5). Values for aggre-
gate diameters from the immunofluorescence micrographs and
from the electron micrographs agree well with each other. Our
data show that aggregates of wild-type lamin A are on average
smaller than those seen with the G465D and R527P mutant
lamins, and these in turn are smaller than those seen with the
R482L mutation.
However, mutants causing a particular disease could not
be placed into groups by looking at features of the aggre-
gates. For example, G465D, a mutation characteristic of
patients with FPLD, and R527P, a mutation characteristic of
patients with EDMD, appeared to form very similar aggre-
gates at both the light and electron microscopic levels. The
R482L mutant (FPLD) formed aggregates that were larger
than those seen in the other two mutants both by light and
electron microscopy.
Effect of mutations on nuclear stability
Abnormal nuclear envelope herniations have been de-
tected in fibroblasts from patients with FPLD subjected to
heat shock [37]. No such effects were seen when the lamin
A mutants used in this study were subjected to the same
conditions. Instead the nuclei retained their usual shape
even though most of the lamin A and lamin C, as well as the
other lamins and lamin-associated proteins, were recruited
into the aggregates. Lamin A was not extractable by Triton
X-100 as judged by immunofluorescence microscopy of
cells transfected with the mutants or with the wild-type [46].
Influence of aggregates on other lamins and on lamin-
associated proteins
Lamins C, B1, and B2 are recruited into the aggregates.
In cells with aggregates little staining of the nuclear lamina
is seen with the lamin C-specific antibodies, but the lamina
is more strongly stained with the B1 and B2 antibodies. The
lamin-associated proteins LAP2 and emerin were also re-
cruited into aggregates, and these proteins are also found in
the nuclear lamina in cells with aggregates. Also, the nu-
clear pore protein Nup153 is found associated with the
aggregates (Fig. 4).
Emerin staining was detected as a ring-like stain around
some but not all aggregates. For the R527P mutant no
change was seen in the level of emerin under the nuclear
membrane when cells with aggregates were examined. This
mutation, therefore, like the R482W/Q mutations studied at
24 h by O¨ stlund et al. [39], appears not to exert a dominant
negative effect on emerin localization at the nuclear mem-
brane. This is in contrast to a variety of other lamin A
mutations studied by others [38,39] in which up to 50% of
the cells show a loss of nuclear envelope-associated emerin.
In addition, cell type-specific alterations in emerin distribu-
tion and nuclear envelope fragility have been reported in
mice lacking the A-type lamins [24]. Staining of nuclear
aggregates with emerin antibodies has not always been seen
in previous studies [38,39], and such staining may therefore
be associated with particular mutations in the lamin A gene
and/or with late times post transfection.
It remains an intriguing question how different mutations
in a single gene can result in six different diseases. Three
mechanisms have been suggested [13,29,48]. First that nu-
clei in cells with lamin A mutations are more fragile, second
that the nuclear envelope may play a significant role in
regulating gene expression patterns, and third that there
could be a knock-on effect dependent on the complement of
proteins found in the endoplasmic reticulum. Currently nei-
ther we or others can decide between these mechanisms, nor
is it clear whether a single mechanism can explain all six
laminopathies. Nevertheless, our data suggest that in tissue
culture the answer is most likely to come from studies such
as that of Vigouroux et al. [37] in which the level of lamin
A expression within the cells is not perturbed. This is
perhaps particularly important insofar as four of the six
diseases result from heterozygous mutations in the lamin A
gene.
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